NEW YORK (GenomeWeb News) – Affymetrix disclosed in a filing with the US Securities and Exchange Commission that it has entered into an agreement to repurchase $69.1 million of its 3.5 percent senior convertible notes due 2038.

The firm said that it entered into the agreement yesterday to repurchase the notes in private transactions. It expects to pay a total consideration of $50.6 million in cash and close the repurchase on June 2.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.